Measurement of Varicella-Zoster Virus (VZV)-specific cell-mediated immunity: Comparison between VZV skin test and interferon-γ enzyme-linked immunospot assay

Kay Sadaoka, Shigefumi Okamoto, Yasuyuki Gomi, Takeshi Tanimoto, Toyokazu Ishikawa, Tetsushi Yoshikawa, Yoshizo Asano, Koichi Yamanishi, Yasuko Mori

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Cell-mediated immunity (CMI) is critical for the prevention and control of varicella-zoster virus (VZV)-related disease. To assess CMI to VZV, a varicella skin test and interferon-γ enzyme-linked immunospot (ELISPOT) assay were both performed in healthy volunteers, and the results were compared. A total of 151 subjects were examined: 16 aged 20-29 years, 26 aged 30-39 years, 18 aged 40-49 years, 73 aged 50-59 years, and 18 aged 60-69 years. All were seropositive by a glycoprotein antigen- based enzyme-linked immunosorbent assay (gpELISA). Skin test reactivity was significantly correlated with the ELISPOT count, and both decreased with increasing age, indicating an age-dependent decline in CMI to VZV. In contrast, the antibody titer obtained by the gpELISA did not correlate with skin test reactivity. The results suggest that the skin test and ELISPOT assay are both reliable for assessing CMI to VZV and can easily be applied to screen individuals susceptible to the development of herpes zoster.

Original languageEnglish
Pages (from-to)1327-1333
Number of pages7
JournalJournal of Infectious Diseases
Volume198
Issue number9
DOIs
Publication statusPublished - 01-11-2008

Fingerprint

Enzyme-Linked Immunospot Assay
Human Herpesvirus 3
Skin Tests
Cellular Immunity
Interferons
Glycoproteins
Enzyme-Linked Immunosorbent Assay
Antigens
Chickenpox
Herpes Zoster
Virus Diseases
Healthy Volunteers
Antibodies
Enzymes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Sadaoka, Kay ; Okamoto, Shigefumi ; Gomi, Yasuyuki ; Tanimoto, Takeshi ; Ishikawa, Toyokazu ; Yoshikawa, Tetsushi ; Asano, Yoshizo ; Yamanishi, Koichi ; Mori, Yasuko. / Measurement of Varicella-Zoster Virus (VZV)-specific cell-mediated immunity : Comparison between VZV skin test and interferon-γ enzyme-linked immunospot assay. In: Journal of Infectious Diseases. 2008 ; Vol. 198, No. 9. pp. 1327-1333.
@article{3ccce45994074d07957fcb7eb6901bf5,
title = "Measurement of Varicella-Zoster Virus (VZV)-specific cell-mediated immunity: Comparison between VZV skin test and interferon-γ enzyme-linked immunospot assay",
abstract = "Cell-mediated immunity (CMI) is critical for the prevention and control of varicella-zoster virus (VZV)-related disease. To assess CMI to VZV, a varicella skin test and interferon-γ enzyme-linked immunospot (ELISPOT) assay were both performed in healthy volunteers, and the results were compared. A total of 151 subjects were examined: 16 aged 20-29 years, 26 aged 30-39 years, 18 aged 40-49 years, 73 aged 50-59 years, and 18 aged 60-69 years. All were seropositive by a glycoprotein antigen- based enzyme-linked immunosorbent assay (gpELISA). Skin test reactivity was significantly correlated with the ELISPOT count, and both decreased with increasing age, indicating an age-dependent decline in CMI to VZV. In contrast, the antibody titer obtained by the gpELISA did not correlate with skin test reactivity. The results suggest that the skin test and ELISPOT assay are both reliable for assessing CMI to VZV and can easily be applied to screen individuals susceptible to the development of herpes zoster.",
author = "Kay Sadaoka and Shigefumi Okamoto and Yasuyuki Gomi and Takeshi Tanimoto and Toyokazu Ishikawa and Tetsushi Yoshikawa and Yoshizo Asano and Koichi Yamanishi and Yasuko Mori",
year = "2008",
month = "11",
day = "1",
doi = "10.1086/592219",
language = "English",
volume = "198",
pages = "1327--1333",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "9",

}

Measurement of Varicella-Zoster Virus (VZV)-specific cell-mediated immunity : Comparison between VZV skin test and interferon-γ enzyme-linked immunospot assay. / Sadaoka, Kay; Okamoto, Shigefumi; Gomi, Yasuyuki; Tanimoto, Takeshi; Ishikawa, Toyokazu; Yoshikawa, Tetsushi; Asano, Yoshizo; Yamanishi, Koichi; Mori, Yasuko.

In: Journal of Infectious Diseases, Vol. 198, No. 9, 01.11.2008, p. 1327-1333.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Measurement of Varicella-Zoster Virus (VZV)-specific cell-mediated immunity

T2 - Comparison between VZV skin test and interferon-γ enzyme-linked immunospot assay

AU - Sadaoka, Kay

AU - Okamoto, Shigefumi

AU - Gomi, Yasuyuki

AU - Tanimoto, Takeshi

AU - Ishikawa, Toyokazu

AU - Yoshikawa, Tetsushi

AU - Asano, Yoshizo

AU - Yamanishi, Koichi

AU - Mori, Yasuko

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Cell-mediated immunity (CMI) is critical for the prevention and control of varicella-zoster virus (VZV)-related disease. To assess CMI to VZV, a varicella skin test and interferon-γ enzyme-linked immunospot (ELISPOT) assay were both performed in healthy volunteers, and the results were compared. A total of 151 subjects were examined: 16 aged 20-29 years, 26 aged 30-39 years, 18 aged 40-49 years, 73 aged 50-59 years, and 18 aged 60-69 years. All were seropositive by a glycoprotein antigen- based enzyme-linked immunosorbent assay (gpELISA). Skin test reactivity was significantly correlated with the ELISPOT count, and both decreased with increasing age, indicating an age-dependent decline in CMI to VZV. In contrast, the antibody titer obtained by the gpELISA did not correlate with skin test reactivity. The results suggest that the skin test and ELISPOT assay are both reliable for assessing CMI to VZV and can easily be applied to screen individuals susceptible to the development of herpes zoster.

AB - Cell-mediated immunity (CMI) is critical for the prevention and control of varicella-zoster virus (VZV)-related disease. To assess CMI to VZV, a varicella skin test and interferon-γ enzyme-linked immunospot (ELISPOT) assay were both performed in healthy volunteers, and the results were compared. A total of 151 subjects were examined: 16 aged 20-29 years, 26 aged 30-39 years, 18 aged 40-49 years, 73 aged 50-59 years, and 18 aged 60-69 years. All were seropositive by a glycoprotein antigen- based enzyme-linked immunosorbent assay (gpELISA). Skin test reactivity was significantly correlated with the ELISPOT count, and both decreased with increasing age, indicating an age-dependent decline in CMI to VZV. In contrast, the antibody titer obtained by the gpELISA did not correlate with skin test reactivity. The results suggest that the skin test and ELISPOT assay are both reliable for assessing CMI to VZV and can easily be applied to screen individuals susceptible to the development of herpes zoster.

UR - http://www.scopus.com/inward/record.url?scp=54249132503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249132503&partnerID=8YFLogxK

U2 - 10.1086/592219

DO - 10.1086/592219

M3 - Article

C2 - 18774884

AN - SCOPUS:54249132503

VL - 198

SP - 1327

EP - 1333

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 9

ER -